A compound for the treatment of triple negative breast and ovarian cancer

摘要

The present invention includes a method of treating triple negative breast cancer and / or ovarian cancer using therapeutic effective amounts of compounds represented by the structure of formula I.Triple negative breast cancer may be taxane resistant TNBC, taxane sensitive TNBC, and / or transition.In one embodiment, X is not a bond if B of formula I is a thiazole ring.In one embodiment, a in the compound of formula I is India lill.In another embodiment, a is the India Lyl.In another embodiment, a is phenyl.In another embodiment, a is pyridyl.In another embodiment, a is naphthyl.Diagram